Company news

Resonance Health Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Management Transition

June 22, 2023

MRI Fibrosis Provisional Patent Application Lodged

December 20, 2022

Investor Presentation

November 24, 2022

Resonance Health Contracted for Two New Clinical Trials

November 10, 2022

Preliminary Final Report

August 30, 2022

FerriScan Now Available on 3 Tesla (3T) MRI Machines

July 24, 2022

Quarterly Activities/Appendix 4C Cash Flow Report

May 1, 2022

Platform Integration & Partnership Agreement with CARPL.ai

April 4, 2022

US CPT Code Confirmation for LiverSmart

February 6, 2022

Resonance Health Enters China - Pharma Contract Signed

January 27, 2022

Resonance Health Contracted for Third Party Clinical Trial

January 24, 2022

US FDA Clearance for LiverSmart

December 29, 2021

ASO Project New Data

December 19, 2021

LiverSmart Submitted to FDA for US Regulatory Clearance

December 2, 2021

Investor Presentation - Positioning for Growth

November 25, 2021

ASO R&D Project - Filing of Two Patent Applications

November 22, 2021

Thalassaemia International Federation to Deploy FerriSmart

November 11, 2021

Sales & Marketing Update

October 13, 2021

New AI Medical Device

October 12, 2021

Appointment of GM - Global Sales & Marketing

July 27, 2021

Appointment of Managing Director

June 27, 2021

Resignation of CEO & Management Changes

June 3, 2021

Filing of Patent Application

May 23, 2021

R&D Update - Molecular Medicine ASO Project

May 16, 2021

Appendix 4C - quarterly

April 28, 2021

Resonance Health: HepaFat-AI Receives CE Marking

February 24, 2021

HepaFat-AI receives CE Marking

February 23, 2021

HepaFat-AI Receives TGA Approval

February 18, 2021

HepaFat-AI Incorporated into Blackford Analysis

December 23, 2020

HepaFat-AI gains US FDA clearance

December 8, 2020

New Pulmonary Embolism AI Solution Developed

October 5, 2020

Execution of Licence Agreement

September 10, 2020

Resonance Health Files New Provisional Patent

May 24, 2020

Market Update

March 30, 2020

Controlled Placement Facility

March 19, 2020

Licencee & Royalty Agreement with 3DR Laboratories

February 3, 2020

Resonance Health Partners with Siemens Healthineers

November 28, 2019

Resonance Health Partners with Siemens healthineers

November 27, 2019

New AI Tool for Automated Assessment of Liver Fat

November 21, 2019

Resonance Health Files Provisional Patent

November 20, 2019

Resonance Health contracted new clinical trials

July 19, 2019

R&D Activities Update and Appendix 3B

April 30, 2019

Response to ASX Price and Volume Query

April 15, 2019

Execution of Distribution Agreement with EnvoyAI

January 15, 2019

Execution of License Agreement

January 3, 2019

Response to ASX Price and Volume Query

December 11, 2018

FDA Clearance Granted for FerriSmart

December 2, 2018

R&D Tax Incentive

November 20, 2018

R&D Tax Incentive

November 19, 2018

Change of Director's Interest Notice

November 15, 2018

← Newer news releases · Older news releases →

Decks

The 5 newest of 42 decks. Every deck is listed under its year.